Skip to main content

Table 2 Internal consistency of EORTC QLQ-C30 (1A) and QLQ-BN20 (1B)

From: Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients

1A: QLQ-C30

 

Cronbach's alpha (p value)

Overall

0.86 (< 0.001*)

Global

Global status

0.80 (< 0.001*)

Functional

Physical functioning

0.83 (< 0.001*)

Role functioning

0.82 (< 0.001*)

Emotional functioning

0.75 (< 0.001*)

Cognitive functioning

0.63 (< 0.001*)

Social functioning

0.79 (< 0.001*)

Symptoms

Fatigue

0.36 (< 0.001*)

Nausea and vomiting

0.40 (< 0.001*)

Pain

0.46 (< 0.001*)

1B: QLQ-BN20

Overall

0.88 (< 0.001)*

Future uncertainty

0.801 (< 0.001*)

Symptoms

Visual disorder

0.790 (< 0.001*)

Motor dysfunction

0.703 (< 0.001*)

Communication deficit

0.868 (< 0.001*)

  1. *Significant at p-value < 0.05 by reliability analysis